The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and system...
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma : CANCER TECHNOLOGIES
About this item
Full title
Author / Creator
Publisher
New York, NY: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Nature Publishing Group
Subjects
More information
Alternative Titles
Full title
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma : CANCER TECHNOLOGIES
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pascalfrancis_primary_26131979
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_26131979
Other Identifiers
ISSN
1087-0156
E-ISSN
1546-1696